Söndag 9 Mars | 16:02:38 Europe / Stockholm

Prenumeration

2025-03-07 15:44:00

Carlsquare Equity Research has updated its view on Biosergen following the progress made in India and the report for the fourth quarter of 2024.
Read the full update here.